Galectin-10 inhibitors comprise a specialized group of compounds or molecules meticulously engineered to interact with the galectin-10 protein. Galectin-10, also known as eosinophil-derived neurotoxin (EDN), is a protein predominantly found in eosinophils, a type of white blood cell. Galectin-10 is implicated in various immune responses and inflammatory processes. The inhibitors designed for galectin-10 interaction encompass a diverse array of chemical structures, with each compound tailored to engage with this protein in a precise and selective manner.
The core purpose of these inhibitors centers on intricately modulating the activity of galectin-10. By targeting galectin-10, these inhibitors have the potential to influence immune responses and associated inflammatory pathways. The design of galectin-10 inhibitors is rooted in their ability to establish specific interactions with the active sites of the protein, utilizing distinct molecular mechanisms that may hinder or alter its functional properties.The exploration of galectin-10 inhibitors delves into the intricate realm of molecular interactions and immune system regulation, shedding light on the multifaceted orchestration of immune responses and inflammatory cascades.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
TD-139 | 1450824-22-2 | sc-507553 | 5 mg | $739.00 | ||
TD139 is a small molecule inhibitor that has been studied for its potential to inhibit galectin-It has shown promise in research studies as a candidate for fibrosis-related conditions. | ||||||